A complex case of liver echinococcosis after coronavirus infection

The problem of echinococcosis incidence among the population of different countries still remains a pressing issue and is the subject of consideration at international congresses and conferences. The article presents a unique clinical case of multiple localization of giant echinococcal cysts. Two multi-chamber cysts were located in the liver, a giant cyst measuring 15*18*18 cm filled the entire left lobe of the liver, the second cyst measuring 10 cm in diameter was located in the projection of segments 6-7 of the right lobe of the liver, and the patient also had a cyst in the lower segments of the left lung. Of additional interest is the fact that the first clinical signs of echinococcosis appeared in the patient after a coronavirus infection. In this regard, the article considered the pathogenetic features of coronavirus infection and echinococcosis, as well as the course of the disease when they are combined. Based on the results of a comprehensive examination, it was decided to carry out a 2-stage treatment for the patient. First of all, due to the presence of clinical indications from the digestive system, to excise the liver cysts. Then, after the patient’s rehabilitation, proceed to the second stage of treatment: excision of the lung cyst in the thoracic surgery department. The patient underwent left-sided hemihepatectomy, resection of liver segments with a reconstructive-plastic component, cholecystectomy, external drainage of the bile ducts according to Kehr. The postoperative period was uneventful. The patient was discharged from the surgical department with an appointment for planned hospitalization in the thoracic surgery department for the 2nd stage of treatment.

echinococcosis, cysts, surgery, operation, coronavirus infection, clinical case

1. Li T., Su W., Wang Z. et al. Characterization of research trends and prospects on hepatic echinococcosis over the past forty years: a bibliometric analysis.Int J Surg. 2024;110(6):3654-3665. doi: 10.1097/JS9.0000000000001319.

2. Wen H., Vuitton L., Tuxun T. et al. Echinococcosis: Advances in the 21st Century. Clin Microbiol Rev. 2019;32(2): e00075-18. doi: 10.1128/CMR.00075-18.

3. Xu X., Gao C., Ye H. Diagnosis and treatment of a case of hepatic mixed echinococcosis infection combined with distant organ metastasis. J Int Med Res. 2020 Feb;48(2):300060519851651. doi: 10.1177/ 0300060519851651.

4. Brunetti E., Tamarozzi F. Watch-and-wait approach for inactive echinococcal cysts: scoping review update since the issue of the WHO-IWGE Expert Consensus and current perspectives. Curr Opin Infect Dis. 2023;36(5):326-332. doi: 10.1097/QCO.0000000000000943.

5. Chang T., Jung B.K., Chai J.Y. et al. The notable global heterogeneity in the distribution of COVID-19 cases and the association with pre-existing parasitic diseases. PLoS Negl Trop Dis. 2022;16(10): e0010826. doi: 10.1371/journal.pntd.0010826.

6. Fonte L., Acosta A., Sarmiento M.E. et al. COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation. Front Immunol. 2020;11:574910. doi: 10.3389/fimmu.2020.574910.

7. Violi F., Pastori D., Cangemi R. et al. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost. 2020;120(6):949-956. doi: 10.1055/s-0040-1710317.

8. Bourgonje A.R., Abdulle A.E., Timens W. et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251(3):228-248. doi: 10.1002/path.5471.

9. Meng R., Fu Y., Zhang Y. et al. Indoleamine 2,3-dioxygenase 1 signaling orchestrates immune tolerance in Echinococcus multilocularis-infected mice. Front Immunol. 2022;13:1032280. doi: 10.3389/fimmu.2022.1032280.

10. Yapasert R., Khaw-On P., Banjerdpongchai R. et al. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets. Molecules. 2021;26(24):7459. doi: 10.3390/molecules26247459.